de Craecker Francoise 4
4 · X4 Pharmaceuticals, Inc · Filed Jan 5, 2026
Insider Transaction Report
Form 4
de Craecker Francoise
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-01+110,000→ 0 totalExercise: $4.00Exp: 2036-01-01→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date.